Adaptimmune Announces Closing Of IPO
OXFORD, UK and PHILADELPHIA, May 11, 2015 (GLOBE NEWSWIRE) -- Adaptimmune (Nasdaq:ADAP) today announced the closing of its initial public offering of 11,250,000 American Depositary Shares (ADSs) at a...
View ArticleBiondVax Pharmaceuticals Announces Pricing Of U.S. IPO Of 1,910,000 Adss And...
RECHOVOT, Israel, May 11, 2015 (GLOBE NEWSWIRE) -- BiondVax Pharmaceuticals Ltd (Nasdaq:BVXV) (Nasdaq:BVXVW), a clinical stage biopharmaceutical company focused on developing and commercializing...
View ArticleJaguar Animal Health Announces Pricing of IPO
SAN FRANCISCO--(BUSINESS WIRE)--Jaguar Animal Health, Inc. (Nasdaq: JAGX), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and...
View ArticleaTyr Pharma Announces Closing Of Initial Public Offering
SAN DIEGO, May 12, 2015 /PRNewswire/ --aTyr Pharma, Inc. ("aTyr"), today announced the closing of its initial public offering of 6,164,000 shares of its common stock at an initial public offering price...
View ArticleCystic Fibrosis Biotech Nivalis Therapeutics Files for $60 Million IPO
Nivalis Therapeutics Files Registration Statement For Initial Public Offering Of Common StockBOULDER, Colo., May 13, 2015 /PRNewswire/ --Nivalis Therapeutics, Inc., a clinical stage pharmaceutical...
View ArticleClik here to view.
AbbVie, Johnson & Johnson Floated as Possible Suitors For Freshly Flush...
May 14, 2015By Riley McDermid...
View Article3SBio Inc. Sets Target Of $712 Million For Hong Kong IPO
3SBio, a China biopharma based in Shenyang, announced it will seek to raise up to $712 million in its Hong Kong IPO, scheduled for early June. The transaction values 3SBio at up to $2.85 billion. That...
View ArticleAxovant Prices IPO At $15, The Upper End Of The Range
Axovant Sciences Ltd Announces Pricing Of Initial Public OfferingHAMILTON, Bermuda, June 10, 2015 /PRNewswire/ --Axovant Sciences Ltd. (NYSE: AXON), a clinical-stage biopharmaceutical company, today...
View ArticleClik here to view.
Axovant Takes Center Stage With Biggest Biotech IPO Ever, Baby-Faced CEO
June 12, 2015By Mark Terry and
View ArticlevTv Therapeutics Files Registration Statement For Proposed Initial Public...
HIGH POINT, N.C.--(BUSINESS WIRE)--vTv Therapeutics LLC (vTv), a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates,...
View ArticleBioCardia Seeks $58 Million IPO
BioCardia Files Registration Statement For Proposed Initial Public Offering SAN CARLOS, CA--(Marketwired - June 16, 2015) - Highlighted Links http://biocardia.com...
View ArticleCelyad Scores $100.1 Million Gross Proceeds With NASDAQ IPO
Celyad Raises $100.1 Million Gross Proceeds With NASDAQ IPOMONT-SAINT-GUIBERT, Belgium, June 18, 2015 (GLOBE NEWSWIRE) -- Celyad SA (formerly known as Cardio3 BioSciences) (Euronext Brussel:CYAD)...
View ArticleClik here to view.
Billionaire's Aims for $172.5 Million IPO, While Neos Therapeutics Asks for...
June 22, 2015By Riley McDermid...
View ArticleClik here to view.
Ousted Sanofi CEO's PureTech Nabs $171 Million in London IPO
June 19, 2015By Riley McDermid, BioSpace.com Breaking News Sr. Editor Ousted
View ArticleBiotech Neos Therapeutics Files for a $69 Million IPO
Neos Therapeutics, a late stage biotech developing formulations of approved therapies for ADHD, filed on Friday with the SEC to raise up to $69 million in an initial public offering. The Grand Prairie,...
View ArticleNivalis Therapeutics IPO Nets $88M
Nivalis Therapeutics Announces Closing Of Its Initial Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional SharesBOULDER, Colo., June 23, 2015 (GLOBE NEWSWIRE) -- Nivalis...
View ArticleClik here to view.
Massachusetts Debuts Three Biotech IPOs for $235M As Market Roars
June 22, 2015By Riley McDermid, BioSpace.com Breaking News...
View ArticleClik here to view.
Benitec Files $70 Million IPO As Gene Therapy Booms
June 23, 2015By Riley McDermid, BioSpace.com Breaking News Sr. Editor ...
View ArticleClik here to view.
Ritter Takes a Run at Public Markers With $20M IPO
June 24, 2015By Riley McDermid, BioSpace.com Breaking News Sr. Editor Los Angeles...
View ArticleGC Aesthetics Files For A $75 Million IPO
GC Aesthetics, a provider of silicone breast implants in Latin America and EMEA, filed on Wednesday with the SEC to raise up to $75 million in an initial public offering.The Dublin, Ireland-based...
View Article
